Roughly 0.25% to 0.64% of Americans have schizophrenia or a related psychotic disorder, according to the National Institute of Mental Health. Applied to the current U.S. adult population, that translates to somewhere between 650,000 and 1.7 million people. The wide range reflects how different studies count cases: some rely on household surveys, others on clinical interviews, and others on medical records.
Why the Estimates Vary So Much
You may have heard that “about 1% of the population” has schizophrenia. That older figure, repeated for decades, turns out to be an overestimate. More rigorous recent studies consistently place the number lower. The World Health Organization now estimates that schizophrenia affects about 1 in 345 people worldwide (0.29%), rising to roughly 1 in 233 adults (0.43%) when you exclude children, who rarely develop the condition.
The gap between the low and high ends of the U.S. range comes down to methodology. Studies that screen large community samples and use structured diagnostic interviews tend to find lower rates. Studies that also capture people in hospitals, shelters, and correctional facilities, where schizophrenia is overrepresented, push the number higher. People with schizophrenia are also harder to reach in standard household surveys: they may be homeless, institutionalized, or unwilling to participate. That means even the higher estimates may miss some cases.
Who Is Most Affected
Schizophrenia can develop at any age, but it typically appears in the late teens through the early 30s. Men and women develop it at roughly similar overall rates, but the timing differs. Men tend to experience their first episode earlier, often in their late teens or early twenties. Women are more likely to develop symptoms several years later, sometimes not until their late twenties or thirties. This gender gap in onset age has been confirmed across multiple studies and is not simply a result of men seeking help sooner.
The condition is diagnosed across all racial and ethnic groups in the United States, though diagnostic rates vary. Some of that variation reflects genuine differences in risk factors like urbanicity and prenatal stress, while some reflects well-documented disparities in how clinicians assess psychotic symptoms in different populations.
How Schizophrenia Is Diagnosed
A diagnosis requires at least two core symptoms persisting for a significant portion of a month, with overall signs of the disorder lasting six months or longer. The core symptoms include hallucinations (hearing or seeing things others don’t), delusions (fixed false beliefs), disorganized speech, severely disorganized or unusual behavior, and “negative” symptoms like emotional flatness or withdrawal from activities. At least one of the symptoms must be hallucinations, delusions, or disorganized speech.
Beyond the symptoms themselves, a diagnosis also requires a noticeable decline in functioning at work, in relationships, or in self-care. This functional piece matters because it distinguishes schizophrenia from briefer psychotic episodes or other conditions that may share individual symptoms but don’t cause the same sustained impairment.
The $367 Billion Cost
Even at the lower prevalence estimates, schizophrenia imposes enormous costs on the people who live with it and the people around them. A 2024 study published in JAMA Psychiatry estimated the total economic burden at $366.8 billion for that year alone. That figure is far larger than most people would guess, in part because the biggest costs are invisible.
Direct healthcare spending accounted for $36.7 billion. But supportive housing and homelessness-related costs added another $35.2 billion, interactions with the justice system cost $11.9 billion, and Social Security disability benefits totaled $5.1 billion. Together, direct costs came to $75 billion.
Indirect costs dwarfed that number at $291.8 billion. Unemployment and reduced wages among people with schizophrenia accounted for $55.4 billion. The study also put a dollar value on reduced quality of life ($41.4 billion) and shortened life expectancy ($47.5 billion), reflecting the fact that people with schizophrenia die 15 to 20 years earlier than the general population on average, often from cardiovascular disease and metabolic conditions rather than the illness itself.
The single largest cost category was caregiving. Family members and other unpaid caregivers shouldered an estimated $165 billion in lost wages, out-of-pocket expenses, healthcare costs of their own, and reduced productivity. That’s nearly half the total economic burden, borne almost entirely by individuals who don’t have the diagnosis themselves.
What Daily Life Looks Like
The popular image of schizophrenia focuses on its most dramatic symptoms, but for most people living with the condition, the daily reality is defined more by the “negative” symptoms: difficulty feeling motivation, trouble concentrating, social withdrawal, and a blunted emotional range. These symptoms are less visible than hallucinations or delusions but often more disabling over the long term, because they make it harder to hold a job, maintain friendships, and manage basic routines.
With treatment, many people with schizophrenia experience significant improvement in their psychotic symptoms. The challenge is that treatment needs to be sustained, often for life, and the medications carry side effects like weight gain, drowsiness, and metabolic changes that lead many people to stop taking them. Gaps in treatment frequently lead to relapse, hospitalization, and a cycle that becomes harder to break each time. Access to consistent psychiatric care, stable housing, and social support makes a measurable difference in outcomes, but these resources remain difficult to access for many Americans with the condition.